IGP DISU PAYS OPERATIONAL VISIT TO AKWA IBOM, PRESIDES OVER PASSING-OUT CEREMONY OF 1,068 RETRAINED CONSTABLES. (PHOTOS). #PRESS RELEASE.

Image
 IGP DISU PAYS OPERATIONAL VISIT TO  AKWA IBOM, PRESIDES OVER PASSING-OUT CEREMONY OF 1,068 RETRAINED CONSTABLES The Inspector-General of Police, IGP Olatunji Rilwan Disu, psc(+), NPM, today, 30th April 2026, undertook an official visit to Akwa Ibom State, where he paid a courtesy call on the Executive Governor, His Excellency, Pastor Umo Eno, ahead of the passing-out ceremony of retrained Police Constables in Uyo. The engagement with the State Government focused on strengthening institutional collaboration in support of ongoing policing reforms anchored on professionalism, accountability, and intelligence-led operations.  The Inspector-General of Police reaffirmed the commitment of the Nigeria Police Force to building a modern, service-driven institution that prioritizes public trust and operational efficiency. Governor Umo Eno, in his remarks, welcomed the Inspector-General of Police and commended the Nigeria Police Force for its ongoing reforms aimed at improving profe...

CHINESE COVID-19 VACCINE SHOWS PROMISING RESULTS.[PHOTO}.

Chinese COVID-19 vaccine shows promising results - CGTN
   We are all expecting a COVID-19 vaccine that could possibly end the pandemic that has killed more than 330,000 people.
Now the first vaccine candidate from China has finished its phase-1 trial on humans, and the results have been put online for everyone to examine.
The Lancet, a respected medical journal in the UK, published the results on Friday saying it is "safe" and "induces rapid immune response."
The research injected the potential vaccine into 108 volunteers.
They were divided into three groups, each taking a different dose of the vaccine.
The vaccine, classified as "recombinant adenovirus type-5 vectored" (Ad5-nCoV), acts as a natural infection and is especially good at teaching the immune system how to fight the virus.During the next 28 days, no serious reactions were found, meaning the vaccine seemed to be tolerable by humans.Also, antibodies against the SARS-CoV-2 started to surge two weeks after the injection and reached its peak on day 28.The vaccine "warrants further investigation," the paper on The Lancet concluded.A phase-2 clinical trial has started with 508 volunteers involved.The trial was conducted by a team led by Chen Wei, a biology professor from Academy of Military Medical Sciences and a member of the Chinese Academy of Engineering.There are other two vaccines allowed for human trials in China. They are ShaCoVacc and PiCoVacc.-CCTV.
Chinese COVID-19 vaccine shows promising results - CGTN

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).